1. INSERM Unité 661 (G.O., T.E.Y., N.Co., N.R., A.G., M.S., N.Ch., E.G., P.M., P.-F.M.), Institut de Génomique Fonctionelle, 34094 Montpellier, France;
2. Université Montpellier 1, 2 (G.O., T.E.Y., N.R., N.Co., A.G., M.S., N.Ch., E.G., P.M., P.-F.M.), 34967 Montpellier, France;
3. Royal College of Surgeons in Ireland (G.O., T.E.Y., M.S., N.P.), Dublin 2, Ireland;
4. Centre National de la Recherche Scientifique Unité Mixte de Recherche 5203 (G.O., T.E.Y., N.R., N.Co., A.G., M.S., N.Ch., E.G., P.M., P.-F.M.), Institut de Génomique Fonctionelle, 34094 Montpellier, France;
5. Division of Molecular Neuroendocrinology (D.C., I.C.A.F.R.), Medical Research Council National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom;
6. INSERM Unité 837 (F.L., C.V., B.D., V.P.), Department of Development and Plasticity of the Postnatal Brain, Jean-Pierre Aubert Research Center, 59045 Lille, France;
7. University of Lille 2 (F.L., C.V., B.D., V.P.), 59000 Lille, France